Sift Biosciences
PrivateLast Round
Pre Seed
Feb 18, 2026
Total Funding Raised
$4.7M
Company Overview
Sift Biosciences operates in Healthcare & Life Sciences and is based in San Carlos, California. Its latest recorded funding round was a Pre Seed round in February 2026.
Sift Biosciences is a biotechnology company developing a peptide-based immunotherapy platform to treat cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sift Biosciences Comparables
Compare Sift Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Metaphore Biotechnologies | 54% | |
| Corner Therapeutics | 37% | |
| Evaxion A/S | 35% |
For institutional investors. Book with your work email.
Sift Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Feb 18, 2026 | ||||
| Grant | Sep 10, 2024 |
For institutional investors. Book with your work email.
Sift Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HS Chau Women in Enterprising Science (WIES) Program | Grant |
| Plug and Play Tech Center | Pre Seed |
| Valuence Ventures | Pre Seed |
| California Life Sciences FAST Program | Grant |
| Eisai Innovation | Pre Seed |
| Freeflow Ventures | Pre Seed |
| LifeSpan Vision Ventures | Pre Seed |
Sift Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sift Biosciences's valuation, stock price, and market status.
Is Sift Biosciences a public or private company?
Sift Biosciences is a private company.
What is the current stock price of Sift Biosciences?
Sift Biosciences is a private company, so its shares have no public market price. Caplight tracks Sift Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sift Biosciences worth (valuation)?
Valuation information for Sift Biosciences is not publicly available.
Can I buy Sift Biosciences stock?
Sift Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sift Biosciences's last funding round?
Sift Biosciences's most recent funding round was Pre Seed on February 18, 2026.
Who are the main investors in Sift Biosciences?
Key investors in Sift Biosciences include Freeflow Ventures, LifeSpan Vision Ventures.
Will Sift Biosciences IPO soon?
No public IPO plans have been announced for Sift Biosciences.
How can I track Sift Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Sift Biosciences's shares on secondary markets.